Reply #21: if avian flu does jump the species barrier [View All]

[HysteryDiagnosis]

You do greatly underestimate the strength of your own defenses.

While I realize this is not an example of a "non-vaccinated" subject beating avian flu virus, I still don't doubt it can be done.

http://aloevera.com/rel_10_19_04.htm

Carrington’s Nasal Technology for flu Vaccines to
Complete Human Safety Trials Early Next Year


Interview In The Wall Street Transcript Details Moves To Transform
Solid Base Into Faster Growing, Higher Margin Business


IRVING, TX OCT 19 – Carrington Laboratories, Inc. (Nasdaq: CARN) said it expects to complete Phase I human safety trials for its nasal powder, preservative free vaccine delivery technology by March 2005.
The needle-less technology is expected to provide an alternative to injections for vaccines such as the annual injectable flu shots and provide a much faster way to implement mass immunizations in the event of pandemic outbreaks.

In an interview in The Wall Street Transcript, Carrington Chief Executive Office Carlton E. Turner, PhD, said “Our Phase I safety trial in humans with (our technology) for nasal administration will be initiated and finished by the end of the first quarter of next year. At that time we can start serious talks about product development relationships with companies interested in nasal delivery of vaccines…”

Unlike the currently marketed nasal mist flu vaccine which is not cleared for those under 6 or over 50 years of age, Carrington’s technology would overcome this negative, eliminate cold chain distribution problems and can be self administered. The platform can deliver the normal form of killed flu virus which is the basis of current injectable flu shots.


Your immune system is where it is at, and you can bump it up if you know what to do... it's not that difficult.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11591118
1: Cell Immunol. 2001 Aug 1;211(2):143-53. Related Articles, Links

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.

Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D.

Aventis Pasteur Canada Ltd., 1755 Steeles Avenue West, Toronto, Ontario, M2R 3T4, Canada.




And an FYI...

1: Med Mal Infect. 2004 Nov;34(11):499-505. Related Articles, Links
Emergence of new viruses in Asia: is climate change involved?

Article in French

Chastel C.

Laboratoire de virologie, faculte de medecine, 29200 Brest, France. [e-mail]

Tropical Africa is not the only area where deadly viruses have recently emerged. In South-East Asia severe epidemics of dengue hemorrhagic fever started in 1954 and flu pandemics have originated from China such as the Asian flu (H2N2) in 1957, the Hong-Kong flu (H3N2) in 1968, and the Russian flu (H1N1) in 1977. However, it is especially during the last ten years that very dangerous viruses for mankind have repeatedly developed in Asia, with the occurrence of Alkhurma hemorrhagic fever in Saudi Arabia (1995), avian flu (H5N1) in Hong-Kong (1997), Nipah virus encephalitis in Malaysia (1998,) and, above all, the SARS pandemic fever from Southern China (2002). The evolution of these viral diseases was probably not directly affected by climate change. In fact, their emergential success may be better explained by the development of large industry poultry flocks increasing the risks of epizootics, dietary habits, economic and demographic constraints, and negligence in the surveillance and reporting of the first cases.

PMID: 15620053